SPG4 founder effect in French Canadians with hereditary spastic paraplegia

Canadian Journal of Neurological Sciences

Volumn 34, Issue 2, 2007, Pages 211-214

  Meijer, Inge A ^a,b   Dupré, Nicolas ^a,c   Brais, Bernard ^a   Cossette, Patrick ^a   St Onge, Judith ^a   Rioux, Marie France ^d   Benard, Melanie ^a   Rouleau, Guy A ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SPASTIN;

ADULT; AGED; ARTICLE; BLADDER; CANADA; CLINICAL ARTICLE; DEGENERATIVE DISEASE; EXON; FAMILY HISTORY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENOTYPE; HAPLOTYPE; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NORTH AMERICA; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; SPG4 GENE;

EID: 34347227751     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100006065     Document Type: Article

References (35)

1. Harding AE. Hereditary spastic paraplegias. [Review]. Semin Neurol. 1993;13:333-6.
2. Reid E. Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J Med Genet. 2003;40:81-6.
3. Fink JK. Advances in the hereditary spastic paraplegias. Exp Neurol. 2003;184 Suppl 1:S106-10.
4. Simpson MA, Cross H, Proukakis C, Pryde A, Hershberger R, Chatonnet A, et al. Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am J Hum Genet. 2003;73:1147-56.
5. Hodgkinson CA, Bohlega S, Abu-Amero SN, Cupler E, Kambouris M, Meyer BF, et al. A novel form of autosomal recessive pure hereditary spastic paraplegia maps to chromosome 13q14. Neurology. 2002;59:1905-9.
6. Klebe S, Azzedine H, Durr A, Bastien P, Bouslam N, Elleuch N, et al. Autosomal recessive spastic paraplegia (SPG30) with mild ataxia and sensory neuropathy maps to chromosome 2q37.3. Brain. 2006; Jun 129(Pt 6):1456-6.
7. Zuchner S, Kail ME, Nance MA, Gaskell PC, Svenson IK, Marchuk DA, et al. A new locus for dominant hereditary spastic paraplegia maps to chromosome 2p12. Neurogenetics. 2006;7:127-9.
8. Crosby AH, Proukakis C. Is the transportation highway the right road for hereditary spastic paraplegia? Am J Hum Genet. 2002;71:1009-16.
9. Rainier S, Chai JH, Tokarz D, Nicholls RD, Fink JK. NIPA1 gene mutations cause autosomal dominant hereditary spastic paraplegia (SPG6). Am J Hum Genet. 2003;73:967-71.
10. Durr A, Davoine CS, Paternotte C, von Fellenberg J, Cogilinicean S, Coutinho P et al. Phenotype of autosomal dominant spastic paraplegia linked to chromosome 2. Brain. 1996;119 (Pt 5):1487-96.
11. Soderblom C, Blackstone C. Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. Pharmacol Ther. 2006;109:42-56.
12. Depienne C, Tallaksen C, Lephay JY, Bricka B, Poea-Guyon S, Fontaine B, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from that observed in familial cases. J Med Genet. 2006;43:259-65.
13. Errico A, Ballabio A, Rugarli E. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet. 2002;15:153-63.
14. Roll-Mecak A, Vale RD. The Drosophila homologue of the hereditary spastic paraplegia protein, spastin, severs and disassembles microtubules. Curr Biol. 2005;15:650-5.
15. Hazan J, Fonknechten N, Mavel D, Paternotte C, Samson D, Artiguenave F, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet. 1999;23:296-303.
16. Hentati A, Deng HX, Zhai H, Chen W, Yang Y, Hung WY et al. Novel mutations in spastin gene and absence of correlation with age at onset of symptoms. Neurology. 2000;55:1388-90.
17. Burger J, Fonknechten N, Hoeltzenbein M, Neumann L, Bratanoff E, Hazan J, et al. Hereditary spastic paraplegia caused by mutations in the SPG4 gene. Eur J Hum Genet. 2000;8:771-6.
18. Fonknechten N, Mavel D, Byrne P, Davoine CS, Cruaud C, Bonsch D, et al. Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet. 2000;9:637-44.
19. Yip AG, Durr A, Marchuk DA, Ashley-Koch A, Hentati A, Rubinsztein DC, et al. Meta-analysis of age at onset in spastin-associated hereditary spastic paraplegia provides no evidence for a correlation with mutational class. J Med Genet. 2003;40:e106.
20. Meijer I, Hand C, Cossette P, Figlewicz D, Rouleau G. Spectrum of SPG4 mutations in a large collection of North American families with hereditary spastic paraplegia. Arch Neurol. 2002;59:281-6.
21. Meijer IA, Cossette P, Roussel J, Benard M, Toupin S, Rouleau GA. A novel locus for pure recessive hereditary spastic paraplegia maps to 10q22.1-10q24.1. Ann Neurol. 2004;56:579-82.
22. McDermott CJ, Burness CE, Kirby J, Cox LE, Rao DG, Hewamadduma C, et al. Clinical features of hereditary spastic paraplegia due to spastin mutation. Neurology. 2006;67:45-51.
23. Crippa F, Panzeri C, Martinuzzi A, Arnoldi A, Redaelli F, Tonelli A, et al. Eight novel mutations in SPG4 in a large sample of patients with hereditary spastic paraplegia. Arch Neurol. 2006;63:750-5.
24. Sauter S, Miterski B, Klimpe S, Bonsch D, Schols L, Visbeck A, et al. Mutation analysis of the spastin gene (SPG4) in patients in Germany with autosomal dominant hereditary spastic paraplegia. Hum Mutat. 2002;20:127-32.
25. Depienne C, Fedirko E, Forlani S, Cazeneuve C, Ribai P, Feki I, et al. Exon deletions of SPG4 are a frequent cause of hereditary spastic paraplegia. J Med Genet. 2006;43:259-65.
26. Laberge AM, Michaud J, Richter A, Lemyre E, Lambert M, Brais B, et al. Population history and its impact on medical genetics in Quebec. Clin Genet. 2005;68:287-301.
27. Dupre N, Bouchard J-P, Brais B, Rouleau GA. Hereditary ataxia, spastic paraparesis and neuropathy in the French-Canadian population. Can J Neurol Sci. 2006;33:149-57.
28. Kibar Z, Dube MP, Powell J, McCuaig C, Hayflick SJ, Zonana J, et al. Clouston hidrotic ectodermal dysplasia (HED): genetic homogeneity, presence of a founder effect in the French Canadian population and fine genetic mapping. Eur J Hum Genet. 2000;8:372-80.
29. Orlacchio A, Kawarai T, Totaro A, Errico A, St George-Hyslop PH, Rugarli EI, et al. Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol. 2004;61:849-55.
30. Namekawa M, Nelson I, Ribai P, Durr A, Denis E, Stevanin G, et al. A founder effect and mutational hot spots may contribute to the most frequent mutations in the SPG3A gene. Neurogenetics. 2006;7:131-2.
31. Nielsen JE, Johnsen B, Koefoed P, Scheuer KH, Gronbech-Jensen M, Law I, et al. Hereditary spastic paraplegia with cerebellar ataxia: a complex phenotype associated with a new SPG4 gene mutation. Eur J Neurol. 2004;11:817-24.
32. Meyer T, Schwan A, Dullinger JS, Brocke J, Hoffmann KT, Nolte CH, et al. Early-onset ALS with long-term survival associated with spastin gene mutation. Neurology. 2005;65:141-3.
33. Alber B, Pernauer M, Schwan A, Rothmund G, Hoffmann KT, Brummer D, et al. Spastin related hereditary spastic paraplegia with dysplastic corpus callosum. J Neurol Sci. 2005;236:9-12.
34. Nielsen JE, Koefoed P, Kjaergaard S, Jensen LN, Norremolle A, Hasholt L. Prenatal diagnosis of autosomal dominant hereditary spastic paraplegia (SPG4) using direct mutation detection. Prenat Diagn. 2004;24:363-6.
35. Orso G, Martinuzzi A, Rossetto MG, Sartori E, Feany M, Daga A. Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine. J Clin Invest. 2005;115:3026-34.